Russia's Sputnik V vaccine developers question neutrality of EU regulator, want apology
Skip to main content
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
The Business Standard
TUESDAY, MAY 17, 2022
TUESDAY, MAY 17, 2022
  • Home
  • Economy
  • Stocks
  • Analysis
  • World+Biz
  • Sports
  • Splash
  • Features
  • Videos
  • Long Read
  • Games
  • Epaper
  • More
    • COVID-19
    • Bangladesh
    • Infograph
    • Interviews
    • Offbeat
    • Thoughts
    • Podcast
    • Quiz
    • Tech
    • Subscribe
    • Archive
    • Trial By Trivia
    • Magazine
    • Supplement
  • বাংলা
Russia's Sputnik V vaccine developers question neutrality of EU regulator, want apology

Coronavirus chronicle

Reuters
09 March, 2021, 04:25 pm
Last modified: 09 March, 2021, 04:27 pm

Related News

  • Russia gives Credit Bank of Moscow licence to export gold
  • EU needs a few more days for next sanctions package on Russia - Germany
  • EU braces for storm as Ukraine fallout cascades in economy
  • Russia calls Finland, Sweden joining NATO a mistake with 'far-reaching consequences'
  • Neutral Switzerland leans closer to Nato in response to Russia

Russia's Sputnik V vaccine developers question neutrality of EU regulator, want apology

“We demand a public apology from EMA’s Christa Wirthumer-Hoche for her negative comments on EU states directly approving Sputnik V,” the vaccine developers wrote on the official Sputnik V Twitter account

Reuters
09 March, 2021, 04:25 pm
Last modified: 09 March, 2021, 04:27 pm
The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement.  Photo: Reuters
The calculations were based on preliminary data obtained 42 days after the first dose, Russia's health ministry, the state-run Gamaleya research centre and the Russian Direct Investment Fund (RDIF) said in a statement. Photo: Reuters

The developers of Russia's Sputnik V vaccine against Covid-19 on Tuesday questioned the neutrality of the European Medicines Agency (EMA) after an EMA official urged EU members to refrain from approving the Russian vaccine for now.

Christa Wirthumer-Hoche, the head of EMA's management board, told a talk show on Austrian broadcaster ORF on March 7 that she advised European Union countries against granting Sputnik V a national emergency authorisation while EMA was still reviewing the Russian vaccine's safety and effectiveness.

"We demand a public apology from EMA's Christa Wirthumer-Hoche for her negative comments on EU states directly approving Sputnik V," the vaccine developers wrote on the official Sputnik V Twitter account.

"Her comments raise serious questions about possible political interference in the ongoing EMA review," they said.

The developers added that the vaccine had already been approved by 46 countries.

"After postponing Sputnik V review for months, EMA does not have the right to undermine (the) credibility of 46 other regulators that reviewed all of the necessary data," Sputnik V's developers said.

Sputnik V has already been approved or is being assessed for approval in three EU member states - Hungary, Slovakia and the Czech Republic. EU officials have said Brussels could start negotiations with a vaccine maker if at least four member countries request it.

Kirill Dmitriev, head of Russia's RDIF sovereign wealth fund, which markets Sputnik V abroad, told Italian television on Sunday it was collaborating with pharmaceutical company Adienne to produce the vaccine in Italy.

The Italian-Russian Chamber of Commerce later said there were plans for production to start in Italy in June and that the deal paved the way to create the first Sputnik V production facility in Europe.

EMA earlier this month said it would review data from ongoing trials of the vaccine until there was enough evidence for a formal marketing authorisation application.

Top News / World+Biz

Sputnik Covid-19 Vaccine / Russia / EU

Comments

While most comments will be posted if they are on-topic and not abusive, moderation decisions are subjective. Published comments are readers’ own views and The Business Standard does not endorse any of the readers’ comments.

Top Stories

  • Are banks only gainers from dollar crisis?
    Are banks only gainers from dollar crisis?
  • PK Halder wants to return home
    PK Halder wants to return home
  • Exporters for continuation of 0.5% source tax for 5 years 
    Exporters for continuation of 0.5% source tax for 5 years 

MOST VIEWED

  • Customers wait in front of a restaurant in Beijing, China April 15, 2022. REUTERS/Tingshu Wang/Files
    China's economy skids as lockdowns hit factories, retailers
  • A medical worker in a protective suit collects a swab from a resident at a makeshift nucleic acid testing site inside a residential compound under lockdown, amid the coronavirus disease (COVID-19) outbreak in Shanghai, China April 14, 2022. REUTERS/Xihao Jiang
    Shanghai aims for return to normal life from 1 June
  • South Korea's new President Yoon Suk-yeol signs a document as he works at the new Presidential office in Seoul, South Korea, May 10, 2022. Yonhap via REUTERS/File Photo
    S Korea says it will spare no effort to help North Korea amid Covid outbreak
  • North Korean leader Kim Jong Un wears a face mask amid the coronavirus disease (Covid-19) outbreak, while inspecting a pharmacy in Pyongyang, in this undated photo released by North Korea's Korean Central News Agency (KCNA) on May 15, 2022. KCNA via REUTERS
    Kim Jong Un orders North Korea military to 'stabilise' drug supply amid Covid outbreak
  • North Korea reports 15 more suspected Covid-19 deaths
    North Korea reports 15 more suspected Covid-19 deaths
  • Residents line up for nucleic acid tests during lockdown, amid the coronavirus disease (Covid-19) pandemic, in Shanghai, China, May 9, 2022. REUTERS/Aly Song
    Locked-down Shanghai to start gradually reopening malls, other businesses

Related News

  • Russia gives Credit Bank of Moscow licence to export gold
  • EU needs a few more days for next sanctions package on Russia - Germany
  • EU braces for storm as Ukraine fallout cascades in economy
  • Russia calls Finland, Sweden joining NATO a mistake with 'far-reaching consequences'
  • Neutral Switzerland leans closer to Nato in response to Russia

Features

Bitcoin, by far the largest cryptocurrency, is a terrible substitute for government-issued money. Photo: Reuters

Crypto’s wild week offers a much-needed warning

11h | Panorama
Karst Stone Paper Journal: Write on indestructible stone paper

Karst Stone Paper Journal: Write on indestructible stone paper

12h | Brands
Pesky bugs do not stand a chance against this automatic indoor insect trap

Pesky bugs do not stand a chance against this automatic indoor insect trap

12h | Brands
Wazeenah: Turning furniture into a canvas

Wazeenah: Turning furniture into a canvas

12h | Brands

More Videos from TBS

Finland, Sweden decide to join NATO

Finland, Sweden decide to join NATO

3h | Videos
Where you can swim for Tk5

Where you can swim for Tk5

5h | Videos
Cultural activists pay tribute to Hassan Arif

Cultural activists pay tribute to Hassan Arif

8h | Videos
How PK Halder becomes a scamster

How PK Halder becomes a scamster

8h | Videos

Most Read

1
Representative Photo: Pixabay.
Bangladesh

Microplastics found in 5 local sugar brands

2
Mushfiq Mobarak. Photo: Noor-A-Alam
Panorama

Meet the Yale professor who anchors his research in Bangladesh and scales up interventions globally

3
Impact of falling taka against US dollar
Banking

Taka losing more value as global currency market volatility persists

4
Govt tightens belt to relieve reserve
Economy

Govt tightens belt to relieve reserve

5
Union Capital asked to return Tk100cr FDR to BATBC 
Banking

Union Capital asked to return Tk100cr FDR to BATBC 

6
How Bangladesh can achieve edible oil self-sufficiency with local alternatives
Bazaar

How Bangladesh can achieve edible oil self-sufficiency with local alternatives

The Business Standard
Top
  • Home
  • Entertainment
  • Sports
  • About Us
  • Bangladesh
  • International
  • Privacy Policy
  • Comment Policy
  • Contact Us
  • Economy
  • Sitemap
  • RSS

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net

Copyright © 2022 THE BUSINESS STANDARD All rights reserved. Technical Partner: RSI Lab